157 related articles for article (PubMed ID: 27578827)
61. [Molecular Pathogenesis of Thyroid Nodules: Relevance for Clinical Care].
Führer D; Musholt T; Schmid KW
Laryngorhinootologie; 2017 Sep; 96(9):590-596. PubMed ID: 28881369
[TBL] [Abstract][Full Text] [Related]
62. Update on the molecular diagnosis and targeted therapy of thyroid cancer.
Liu M; Ruan M; Chen L
Med Oncol; 2014 Jun; 31(6):973. PubMed ID: 24788398
[TBL] [Abstract][Full Text] [Related]
63. The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications.
Rodrigues AC; Penna G; Rodrigues E; Castro P; Sobrinho-Simões M; Soares P
Curr Genomics; 2017 Jun; 18(3):244-254. PubMed ID: 28659720
[TBL] [Abstract][Full Text] [Related]
64. Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study.
Yip L; Gooding WE; Nikitski A; Wald AI; Carty SE; Karslioglu-French E; Seethala RR; Zandberg DP; Ferris RL; Nikiforova MN; Nikiforov YE
Cancer; 2021 Jun; 127(11):1779-1787. PubMed ID: 33539547
[TBL] [Abstract][Full Text] [Related]
65. Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario.
Galuppini F; Vianello F; Censi S; Barollo S; Bertazza L; Carducci S; Colato C; Manso J; Rugge M; Iacobone M; Watutantrige Fernando S; Pennelli G; Mian C
Front Endocrinol (Lausanne); 2019; 10():552. PubMed ID: 31456750
[No Abstract] [Full Text] [Related]
66. Heterogeneity of Thyroid Cancer.
Chmielik E; Rusinek D; Oczko-Wojciechowska M; Jarzab M; Krajewska J; Czarniecka A; Jarzab B
Pathobiology; 2018; 85(1-2):117-129. PubMed ID: 29408820
[TBL] [Abstract][Full Text] [Related]
67. RAS mutations in thyroid cancer.
Howell GM; Hodak SP; Yip L
Oncologist; 2013; 18(8):926-32. PubMed ID: 23873720
[TBL] [Abstract][Full Text] [Related]
68. Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
Toda S; Hiroshima Y; Iwasaki H; Masudo K
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38630010
[TBL] [Abstract][Full Text] [Related]
69. Molecular genetics of thyroid cancer.
Rebaї M; Rebaї A
Genet Res (Camb); 2016 May; 98():e7. PubMed ID: 27174043
[TBL] [Abstract][Full Text] [Related]
70. Genetic and epigenetic alterations in differentiated thyroid carcinoma.
Brehar AC; Brehar FM; Bulgar AC; Dumitrache C
J Med Life; 2013; 6(4):403-8. PubMed ID: 24868250
[TBL] [Abstract][Full Text] [Related]
71. Advances in Molecular Profiling and Their Potential Influence on the Extent of Surgery in Well-Differentiated Thyroid Carcinoma (WDTC).
Parpounas C; Constantinides V
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374164
[TBL] [Abstract][Full Text] [Related]
72. [The role of molecular testing in thyroid tumors].
Kachko VA; Platonova NM; Vanushko VE; Shifman BM
Probl Endokrinol (Mosk); 2020 Sep; 66(3):33-46. PubMed ID: 33351337
[TBL] [Abstract][Full Text] [Related]
73. Emerging Biomarkers in Thyroid Practice and Research.
Agarwal S; Bychkov A; Jung CK
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008368
[TBL] [Abstract][Full Text] [Related]
74. Genomic alterations in thyroid cancer: biological and clinical insights.
Landa I; Cabanillas ME
Nat Rev Endocrinol; 2024 Feb; 20(2):93-110. PubMed ID: 38049644
[TBL] [Abstract][Full Text] [Related]
75. Re: "Risk Stratification Using a Novel Genetic Classifier Including
Landa I
Thyroid; 2021 Apr; 31(4):703-704. PubMed ID: 33191868
[No Abstract] [Full Text] [Related]
76. Current concepts and future directions in differentiated thyroid cancer.
McLeod DS
Clin Biochem Rev; 2010 Feb; 31(1):9-19. PubMed ID: 20179793
[TBL] [Abstract][Full Text] [Related]
77. Comment on "Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations".
Shaha AR
Gland Surg; 2018 Oct; 7(5):426-427. PubMed ID: 30505762
[No Abstract] [Full Text] [Related]
78. [Genetic alterations in hematological neoplasias of lymphoid origin: implications for clinical practice].
Vizmanos JL; Agirre X; Calasanz MJ; García M; Novo FJ
An Sist Sanit Navar; 2000; 23(3):451-65. PubMed ID: 12886300
[TBL] [Abstract][Full Text] [Related]
79. Editorial: Application of advances in molecular and genetic researches to tackle pancreatic cancer: screening, diagnosis, prognostication and drug response prediction.
Ibrahem S; AlGhamdi S
Front Genet; 2023; 14():1320082. PubMed ID: 38075687
[No Abstract] [Full Text] [Related]
80. Prognostication in Metastatic Solid Tumours: Medical Community General Knowledge.
Gameiro-Santos R; Fernandes IG; Luz P
BMJ Support Palliat Care; 2022 Mar; ():. PubMed ID: 35332028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
